Obstructive sleep apnea (OSA) is a common disorder associated with cardiovascular
disease (CVD). One theory to explain this relationship proposes that OSA can induce …

Obstructive sleep apnea (OSA) is thought to affect almost 1 billion people worldwide. OSA
has well established cardiovascular and neurocognitive sequelae, although the optimal …

Objectives: Obstructive sleep apnea syndrome (OSA) results in oxygen desaturation and
arousal from sleep. Free oxygen radicals are highly reactive molecules, which can be …

In the past two decades, obstructive sleep apnoea (OSA) has been identified as a common
clinical condition. Epidemiological studies have confirmed a high prevalence of the disease …

Obstructive sleep apnea–hypopnea syndrome (OSAHS) with episodic hypoxia–
reoxygenation is associated with increased cardiovascular morbidity and mortality …

Metabolic syndrome (MS), the commonly used term for the clustering of obesity, insulin
resistance, hypertension, and dyslipidemia, affects millions of people worldwide, and is …

Rationale: Data from population-based cohorts suggest that symptom subtypes and
obstructive sleep apnea (OSA)–specific hypoxic burden (HB) could help to better identify …

Obstructive sleep apnea (OSA), characterized by repetitive episodes of apnea/hypopnea
and hypoxia, is associated with systemic inflammation and induces metabolic, endocrine …

Aim To seek accurate and credible correlation manner between gender, age, and obesity;
and the severity of obstructive sleep apnea (OSA) in large-scale population. Methods Totals …

Obstructive sleep apnea (OSA) shares many cardiovascular risk factors with metabolic
syndrome, including obesity, hypertension, insulin resistance, and pro-inflammatory state …